Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

25

Revenue 2017

Genvoya

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Genvoya was produced by Gilead Sciences.

Gilead awaits CEO and readouts to revive fortunes

Gilead awaits CEO and readouts to revive fortunes

Genvoya. In Europe, Gilead says it is encouraged by uptake in Germany and France, and anticipates launches in Spain, Italy and the UK by mid-2019.

MSD claims EU approval for two HIV products

MSD claims EU approval for two HIV products In the US, Merck has priced Delstrigo at $70 per day, at the low end of rivals such as Gilead’s Genvoya (elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide) and ViiV’s Triumeq

Gilead plans fightback against HIV arch-rival ViiV

Gilead plans fightback against HIV arch-rival ViiV its Genvoya and Stribild products - which needs to be boosted with cobicistat.

Gilead gets EU nod for TAF-based triple therapy for HIV

Gilead gets EU nod for TAF-based triple therapy for HIV also bagged approval for four-drug Genvoya (elvitegravir, emtricitabine, cobicistat and TAF), an updated version of the company's $1.8bn Stribild brand. ... In the first 18 weeks from launch in the US last November, Genvoya's uptake is outpacing Gilead's

Gilead bags EU approval for next-generation HIV drug

Gilead bags EU approval for next-generation HIV drug Four-drug product Genvoya (elvitegravir, emtricitabine, cobicistat and TAF) was approved in its first markets last year and is positioned to replace Gilead's $1.8bn Stribild brand.

1 2 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Fishawack Group of Companies

The Fishawack Group of Companies is one of the largest independent medical communications and medical marketing specialists, with teams in...

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics